MedPath
NMPA Approval

Urokinase for Injection

国药准字H22023407

June 25, 2019

Drug Information

注射用尿激酶

注射剂

100万单位

化学药品

June 25, 2019

Company Information

Applicant Company

江西省南昌市高新技术产业开发区尤口路369号

Manufacturing Company

江西省南昌市高新技术产业开发区尤口路369号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用尿激酶 - NMPA 批准文号 | MedPath